Correlation between Thrombin Generation, Standard Coagulation Assays, and Viscoelastic Assays for Hemostatic

Kimberly A Thomas1, Susan M Shea1, Arun Saini2

  • 1Division of Critical Care Medicine, Department of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, MO.

Insights

Thrombin generation (TG) assays correlate variably with standard coagulation tests in critically ill children. Thromboelastography kinetic time (TEG-K) showed the most consistent correlation with endogenous thrombin potential (ETP).

Area of Science:

  • Pediatric critical care medicine
  • Hemostasis and thrombosis research
  • Clinical laboratory diagnostics

Background:

  • Accurate assessment of hemostatic function is crucial for managing coagulopathies in critically ill children.
  • Thrombin generation (TG) assays offer a global evaluation of procoagulant and anticoagulant factors, widely used in research.
  • This study aimed to correlate standard hemostasis assays with TG in pediatric intensive care unit patients.

Purpose of the Study:

  • To evaluate the correlation between clinically available hemostasis assays and thrombin generation (TG) in critically ill children.
  • To determine which assays best reflect the global hemostatic status as assessed by TG.

Main Methods:

  • A prospective, 2-center study enrolled 106 critically ill children (March 2016-December 2019).
  • Assays included prothrombin time, activated thromboplastin time, anti-Xa, viscoelastic assays (thromboelastography [TEG], rotational thromboelastometry [ROTEM]), and TG (endogenous thrombin potential [ETP]).
  • Patients were stratified into non-anticoagulated, anticoagulated without extracorporeal life support, and anticoagulated with extracorporeal life support groups.

Main Results:

  • Endogenous thrombin potential (ETP) was significantly lower in anticoagulated patients compared to non-anticoagulated patients (P < 0.0001).
  • Across all patients, ETP showed the strongest correlation with TEG kinetic time (TEG-K; ρ = -0.639) and TEG reaction time (ρ = -0.596).
  • Group-specific correlations varied, with ETP correlating best with international normalized ratio in non-anticoagulated patients, TEG-K in those anticoagulated without extracorporeal life support, and anti-Xa in those with extracorporeal life support.

Conclusions:

  • Standard and viscoelastic hemostasis assays demonstrate variable correlations with thrombin generation (TG) in critically ill children.
  • Thromboelastography kinetic time (TEG-K) exhibited the most consistent moderate correlation with endogenous thrombin potential (ETP) across all patient groups.
  • These findings highlight the complexity of assessing hemostasis in critically ill children and suggest TEG-K as a potentially valuable indicator of TG.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
46
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
33
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
940
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.4K